XBiotech Inc Strategic Asset Allocation Index
XBiotech Inc strategic asset allocation index. XBiotech Inc (XBIT) has a Strategic Asset Allocation Index of 11.2% as of June 2023. Strategic assets (PP&E of $25.62 Million plus long-term investments of $-) total $25.62 Million, measured against net assets of $229.06 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See XBiotech Inc net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of XBiotech Inc (2013–2022)
Strategic asset allocation index of XBiotech Inc from 2013 to 2022. This chart shows how XBiotech Inc's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 11.2%, representing strategic assets of $25.62 Million against net assets of $229.06 Million USD. Check XBiotech Inc (XBIT) tangible equity ratio to evaluate the tangible quality of the company's equity base.
XBiotech Inc Strategic Asset Allocation Index by Year (2013–2022)
XBiotech Inc strategic asset allocation index by year from 2013 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for XBiotech Inc from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of XBiotech Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 10.9% | $26.26 Million | $26.26 Million | $- | $240.40 Million | ▲ +0.4 pp |
| 2021 | 10.5% | $28.31 Million | $28.31 Million | $- | $269.38 Million | ▲ +2.7 pp |
| 2020 | 7.8% | $27.34 Million | $27.34 Million | $- | $348.64 Million | ▲ +4.5 pp |
| 2019 | 3.3% | $25.17 Million | $25.17 Million | $- | $755.63 Million | ▼ -62.7 pp |
| 2018 | 66.0% | $27.33 Million | $27.33 Million | $- | $41.40 Million | ▲ +16.7 pp |
| 2017 | 49.3% | $29.64 Million | $29.64 Million | $- | $60.16 Million | ▲ +32.1 pp |
| 2016 | 17.2% | $10.14 Million | $10.14 Million | $- | $59.06 Million | ▲ +11.4 pp |
| 2015 | 5.8% | $5.95 Million | $5.95 Million | $- | $103.05 Million | ▼ -1.2 pp |
| 2014 | 7.0% | $4.11 Million | $4.11 Million | $- | $59.03 Million | ▼ -26.1 pp |
| 2013 | 33.0% | $3.38 Million | $3.38 Million | $- | $10.23 Million | — |